Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wrong-Site Surgery Occurs 40 Times a Week

By HospiMedica International staff writers
Posted on 20 Jul 2011
Preliminary results of a new study show that there is usually no single root cause for wrong-site surgery, and that these events are frequently the result of a cascade of small errors.

Researchers participating in the US Joint Commission Center for Transforming Healthcare (Oakbrook Terrace, IL, USA) announced the preliminary results of a project involving eight hospitals and ambulatory surgery centers. More...
The facilities found that problems with scheduling and preoperative/holding processes, as well as ineffective communication and distractions in the operating room, contributed to increasing the risk for wrong-site surgery. A "time out" without full participation by all key people in the operating room was identified as another contributing factor that increased risk.

Unapproved pens used to mark the surgery site were also a part of the problem; sometimes the mark was washed away during the patient preparation. Making certain that only approved indelible pens are used was therefore a simple but important intervention. The facilities also found that addressing documentation and verification issues in the preoperative and holding areas decreased defective cases that increase the risk for wrong-site surgery from a baseline of 52% to 19%. In turn, the incidence of cases containing more than one defect decreased by 72%.

“We found that in 39% of cases, errors were introduced that increased risk,” said president of the joint commission Mark Chassin, MD, MPP, MPH. “The biggest was inadequate information about the patient. Often, the information is taken by a staffer in the surgeon's office, who may have to deal with several hospitals and different protocols. Confusion can result. The solution is a carefully standardized way of collecting information.”

“The 8 hospitals identified where errors can creep into the process and took steps to correct them. All facilities and physicians who perform invasive procedures are at some degree of risk; the magnitude of this risk is often unknown or undefined,” added Dr. Chassin. “Providers who ignore this fact, or rely on the absence of such events in the past as a guarantee of future safety, do so at their peril. Unless an organization has taken a systematic approach to studying its own processes, it is flying blind.”

Related Links:

Joint Commission Center for Transforming Healthcare




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.